Ace the HeartCode ACLS 2026 Online Challenge – Pump Up Your Skills and Save Lives!

Administering anticoagulants immediately after thrombolytic therapy is generally not a standard protocol due to the risk of bleeding. Thrombolytics are used to dissolve blood clots during events like a heart attack or stroke, and they can increase the risk of hemorrhage. Therefore, anticoagulants, which also affect blood clotting, are typically avoided immediately following thrombolysis until the risk of bleeding is thoroughly assessed.

In contrast, closely monitoring vital signs is essential to detect any changes in the patient’s condition early, ensuring immediate action can be taken if complications arise. Performing neurological assessments is crucial, particularly following thrombolysis for stroke, to monitor for any changes that may indicate complications or worsening of the patient's condition. Managing potential bleeding complications is vital to address any adverse effects of thrombolytic therapy, as bleeding is a significant concern following such treatment.